Trial Profile
Delaying the progression of driving impairment in individuals with mild Alzheimer's disease.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Memantine (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 18 Jul 2013 Results presented at the 2013 Alzheimer's Association International Conference .
- 01 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Nov 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.